drugset
drugset / Trial / NCT03686774

Memantine and Post-mastectomy Neuropathic Pain

NCT03686774 ↗

Phase 2 Unknown 150 enrolled University Hospital, Clermont-Ferrand
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to evaluate if memantine administered for four weeks starting two weeks before surgery induces a decrease in pain intensity at 3 months post-mastectomy.

Timeline

Start
2019-02-15
Primary completion
2022-01-31
Completion
2022-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Memantine Unknown 20 mg Oral

Indications

neuropathy, painful